Radiofrequency ablation in spinal osteoid osteoma. Options and limits

Osteoid osteoma was first described by Jaffe in 1935 as a benign bone neoplasm mainly located in the diaphyseal areas of long bones: 10% are located in the spine, mainly in the lumbar and thoracic posterior elements. Therapy is required due to nocturnal pain independent of the physical load and resp...

Full description

Saved in:
Bibliographic Details
Published inDer Orthopäde Vol. 41; no. 8; p. 618
Main Authors Omlor, G W, Lehner, B, Wiedenhöfer, B, Deininger, C, Weber, M A, Rehnitz, C
Format Journal Article
LanguageGerman
Published Germany 01.08.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Osteoid osteoma was first described by Jaffe in 1935 as a benign bone neoplasm mainly located in the diaphyseal areas of long bones: 10% are located in the spine, mainly in the lumbar and thoracic posterior elements. Therapy is required due to nocturnal pain independent of the physical load and responds especially well to anti-inflammatory drugs due to the excessive production of prostaglandins in the nidus. Diagnosis is confirmed by multi-slice computed tomography (CT), magnetic resonance imaging (MRI) and skeletal scintigraphy scans. In cases with typical symptoms and imaging, open biopsies are rarely needed. Although CT-guided radiofrequency ablation is accepted as the gold standard treatment option for osteoid osteoma in the extremities, this technique is limited in spinal applications due to the risk of thermal damage to adjacent neurovascular structures. Technical advances in the administration of radiofrequency ablation have, however, resulted in new and expanded indications in the spine so that the necessity for open surgical excision of spinal osteoid osteoma is becoming less.
ISSN:1433-0431
DOI:10.1007/s00132-012-1907-x